Variant report
Variant | esv3352546 |
---|---|
Chromosome Location | chr13:80200623-80201077 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4885648 | chr13:80200682-80200683 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs541540748 | chr13:80200710-80200711 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs77939173 | chr13:80200736-80200737 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547720406 | chr13:80200752-80200753 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559740805 | chr13:80200768-80200769 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374855186 | chr13:80200779-80200780 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555431476 | chr13:80200787-80200788 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs369267083 | chr13:80200788-80200789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577602976 | chr13:80200799-80200800 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537895874 | chr13:80200801-80200802 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs558268463 | chr13:80200819-80200820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs578163990 | chr13:80200830-80200831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545993398 | chr13:80200835-80200836 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553218454 | chr13:80200850-80200851 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs573012357 | chr13:80200854-80200855 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs189498579 | chr13:80200888-80200889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs561880319 | chr13:80200889-80200890 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs9565512 | chr13:80200895-80200896 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs139550652 | chr13:80200990-80200991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs181805553 | chr13:80201024-80201025 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs149750706 | chr13:80201043-80201044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546751783 | chr13:80201044-80201045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 21364760 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Schizophrenia | 19197363 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:80195600-80202200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr13:80198600-80203800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr13:80198600-80205200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
4 | chr13:80199400-80204200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr13:80199600-80202200 | Enhancers | HMEC | breast |
6 | chr13:80200400-80201600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |